5650EGP
- Active ingredient
- dactinomycin(actinomycin d)
- Strength
- 500mcg
- Form
- vial
- Manufacturer
- orphan europe >
- Route
- injection
Uses
Used in combination chemotherapy regimens for Wilms tumor, rhabdomyosarcoma, Ewing sarcoma, and certain testicular cancers.
Do not use if
No specific absolute contraindications listed; hypersensitivity requires caution.
Side effects
Myelosuppression, mucositis, nausea, vomiting, and injection site complications may occur.
Warnings
May cause severe myelosuppression, veno-occlusive disease, and secondary malignancies.
How it works
A cytotoxic antibiotic that binds DNA and inhibits RNA synthesis.
Storage
Store according to manufacturer instructions and protect from excessive heat.